IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways

We previously reported that antitumor B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10. In this study, we defined additional mechanisms involved in B cell antitumor immunity. Administration of IL-2 significantly augmented the therapeutic efficacy of adoptively tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yang, Tao, Huimin, Hu, Yangyang, Chen, Quanning, Chen, Xin, Xia, Leiming, Zhou, Li, Wang, Yi, Bao, Yangyi, Huang, Shiang, Ren, Xiubao, Lundy, Steven K., Dai, Fu, Li, Qiao, Chang, Alfred E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312396/
https://www.ncbi.nlm.nih.gov/pubmed/27528023
http://dx.doi.org/10.18632/oncotarget.11124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312396/
https://www.ncbi.nlm.nih.gov/pubmed/27528023
http://dx.doi.org/10.18632/oncotarget.11124

Ejemplares similares